Amneal Pharmaceuticals, Inc. Stock price
Equities
AMRX
US03168L1052
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.06 USD | -0.98% | -3.66% | -0.16% |
Mar. 25 | Amneal Pharma Gets FDA Nod for Infection Fighting Drug Combination | DJ |
Mar. 25 | Amneal Pharmaceuticals Receives FDA Approval for Ear Infection Treatment | MT |
Financials (USD)
Sales 2024 * | 2.6B | Sales 2025 * | 2.73B | Capitalization | 1.87B |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | 22M | EV / Sales 2024 * | 1.6 x |
Net Debt 2024 * | 2.29B | Net Debt 2025 * | 2.07B | EV / Sales 2025 * | 1.45 x |
P/E ratio 2024 * |
121
x | P/E ratio 2025 * |
67.3
x | Employees | 7,850 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.86% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | -0.98% | ||
1 week | -3.66% | ||
Current month | +9.78% | ||
1 month | +9.78% | ||
3 months | -0.98% | ||
6 months | +39.95% | ||
Current year | -0.16% |
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | Nov. 06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | Nov. 06 |
J. Buchi
BRD | Director/Board Member | 69 | Nov. 06 |
Paul Meister
CHM | Chairman | 71 | Nov. 06 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 6.06 | -0.98% | 2,883,519 |
24-03-27 | 6.12 | +4.62% | 1,913,485 |
24-03-26 | 5.85 | -1.02% | 1,895,661 |
24-03-25 | 5.91 | -2.64% | 889,275 |
24-03-22 | 6.07 | -3.50% | 2,228,526 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.16% | 1.89B | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |